{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:57:45Z","timestamp":1793314665973,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"DOI":"10.1007\/s00270-026-04561-w","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:51:13Z","timestamp":1788979873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: A GRADE-Assessed Systematic Review and Meta-Analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6724-2042","authenticated-orcid":false,"given":"Arsalan","family":"Nadeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawood","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayefa Naveed","family":"Klair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muntaha","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bilal","family":"Sardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"1","key":"4561_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76(1):e70043. https:\/\/doi.org\/10.3322\/caac.70043.","journal-title":"CA Cancer J Clin"},{"key":"4561_CR2","unstructured":"Worldwide cancer data. World Cancer Research Fund. Accessed March 22, 2026. https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/worldwide-cancer-data\/"},{"issue":"5","key":"4561_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/JU.0000000000004995","volume":"215","author":"DW Lin","year":"2026","unstructured":"Lin DW, Carlsson S, Filson CP, et al. Updates to early detection of prostate cancer: AUA\/SUO guideline (2026). J Urol. 2026;215(5):491\u2013501. https:\/\/doi.org\/10.1097\/JU.0000000000004995.","journal-title":"J Urol"},{"issue":"2","key":"4561_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","volume":"190","author":"HB Carter","year":"2013","unstructured":"Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol. 2013;190(2):419\u201326. https:\/\/doi.org\/10.1016\/j.juro.2013.04.119.","journal-title":"J Urol"},{"issue":"2","key":"4561_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86(2):148\u201363. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027.","journal-title":"Eur Urol"},{"issue":"3","key":"4561_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/jama.283.3.354","volume":"283","author":"JL Stanford","year":"2000","unstructured":"Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000;283(3):354\u201360. https:\/\/doi.org\/10.1001\/jama.283.3.354.","journal-title":"JAMA"},{"issue":"12","key":"4561_CR7","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1001\/jamaoncol.2024.4397","volume":"10","author":"JM Unger","year":"2024","unstructured":"Unger JM, Till C, Tangen CM, et al. Long-term adverse effects and complications after prostate cancer treatment. JAMA Oncol. 2024;10(12):1654\u201362. https:\/\/doi.org\/10.1001\/jamaoncol.2024.4397.","journal-title":"JAMA Oncol"},{"key":"4561_CR8","unstructured":"TULSA PRO. Profound Medical. Accessed June 23, 2026. https:\/\/profoundmedical.com\/new-tulsa\/"},{"key":"4561_CR9","unstructured":"K191200. Accessed June 23, 2026. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/K191200.pdf"},{"issue":"6","key":"4561_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00270-024-03696-y","volume":"47","author":"KFK Fung","year":"2024","unstructured":"Fung KFK, Cazzato RL, Tricard T, et al. MR-Guided Transurethral Ultrasound Ablation (TULSA)-An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer. Cardiovasc Intervent Radiol. 2024;47(6):689\u2013701. https:\/\/doi.org\/10.1007\/s00270-024-03696-y.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"4561_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/end.2021.0866","volume":"36","author":"C Dora","year":"2022","unstructured":"Dora C, Clarke GM, Frey G, Sella D. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer: a systematic review. J Endourol. 2022;36(6):841\u201354. https:\/\/doi.org\/10.1089\/end.2021.0866.","journal-title":"J Endourol"},{"key":"4561_CR12","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane. Accessed January 14, 2026. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook"},{"key":"4561_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"4561_CR14","unstructured":"PROSPERO. Accessed January 14, 2026. https:\/\/www.crd.york.ac.uk\/prospero\/"},{"key":"4561_CR15","unstructured":"Levels of evidence. Accessed February 27, 2026. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence"},{"key":"4561_CR16","doi-asserted-by":"publisher","unstructured":"Filippiadis D, Pereira PL, Hausegger KA, Ryan AG, Binkert CA. CIRSE standards of practice for the classification of complications: The Modified CIRSE Classification System. Cardiovasc Intervent Radiol. 2026;49(1):2\u20136. https:\/\/doi.org\/10.1007\/s00270-025-04200-w","DOI":"10.1007\/s00270-025-04200-w"},{"issue":"2","key":"4561_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"key":"4561_CR18","unstructured":"CTCAE and AE Reporting - NCI. June 25, 2025. Accessed February 27, 2026. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events"},{"issue":"4","key":"4561_CR19","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach","year":"2006","unstructured":"Roach M, Hanks G, Thames H, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65(4):965\u201374. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.04.029.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4561_CR20","doi-asserted-by":"publisher","unstructured":"Barry MJ, Fowler FJ, O\u2019Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549\u20131557. https:\/\/doi.org\/10.1016\/s0022-5347(17)36966-5","DOI":"10.1016\/s0022-5347(17)36966-5"},{"issue":"6","key":"4561_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pe\u00f1a BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319\u201326. https:\/\/doi.org\/10.1038\/sj.ijir.3900472.","journal-title":"Int J Impot Res"},{"issue":"6","key":"4561_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/s0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822\u201330. https:\/\/doi.org\/10.1016\/s0090-4295(97)00238-0.","journal-title":"Urology"},{"issue":"9","key":"4561_CR23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712\u20136. https:\/\/doi.org\/10.1046\/j.1445-2197.2003.02748.x.","journal-title":"ANZ J Surg"},{"key":"4561_CR24","unstructured":"R: The R Project for Statistical Computing. Accessed January 22, 2026. https:\/\/www.r-project.org\/"},{"key":"4561_CR25","doi-asserted-by":"publisher","unstructured":"Schwarzer G. meta: General Package for Meta-Analysis. Published online February 8, 2006:8.2\u20131. https:\/\/doi.org\/10.32614\/CRAN.package.meta","DOI":"10.32614\/CRAN.package.meta"},{"issue":"11","key":"4561_CR26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974\u20138. https:\/\/doi.org\/10.1136\/jech-2013-203104.","journal-title":"J Epidemiol Community Health"},{"key":"4561_CR27","unstructured":"Chapter 10: Analysing data and undertaking meta-analyses | Cochrane. Accessed March 22, 2026. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-10"},{"key":"4561_CR28","unstructured":"automeris.io: Computer vision assisted data extraction from charts using WebPlotDigitizer. Accessed June 23, 2026. https:\/\/automeris.io\/"},{"key":"4561_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"4561_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"issue":"3","key":"4561_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"issue":"3","key":"4561_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3102\/10769986030003261","volume":"30","author":"W Viechtbauer","year":"2005","unstructured":"Viechtbauer W. Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educ Behav Stat. 2005;30(3):261\u201393. https:\/\/doi.org\/10.3102\/10769986030003261.","journal-title":"J Educ Behav Stat"},{"issue":"24","key":"4561_CR33","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1002\/sim.1009","volume":"20","author":"J Hartung","year":"2001","unstructured":"Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med. 2001;20(24):3875\u201389. https:\/\/doi.org\/10.1002\/sim.1009.","journal-title":"Stat Med"},{"issue":"7109","key":"4561_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"key":"4561_CR35","unstructured":"Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis | Cochrane. Accessed March 22, 2026. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-13"},{"issue":"S1","key":"4561_CR36","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1089\/end.2024.0301","volume":"39","author":"L Engelage","year":"2025","unstructured":"Engelage L, Muschter R. Transurethral ultrasound ablation for treatment of localized prostate cancer and benign prostatic hyperplasia (BPH). J Endourol. 2025;39(S1):S23\u20136. https:\/\/doi.org\/10.1089\/end.2024.0301.","journal-title":"J Endourol"},{"issue":"7651","key":"4561_CR37","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Sch\u00fcnemann HJ. What is \u201cquality of evidence\u201d and why is it important to clinicians? BMJ. 2008;336(7651):995\u20138. https:\/\/doi.org\/10.1136\/bmj.39490.551019.BE.","journal-title":"BMJ"},{"issue":"7650","key":"4561_CR38","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ"},{"issue":"3","key":"4561_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2015.12.029","volume":"70","author":"JL Chin","year":"2016","unstructured":"Chin JL, Billia M, Relle J, et al. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial. Eur Urol. 2016;70(3):447\u201355. https:\/\/doi.org\/10.1016\/j.eururo.2015.12.029.","journal-title":"Eur Urol"},{"issue":"5","key":"4561_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/21681805.2019.1660707","volume":"53","author":"M Anttinen","year":"2019","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Suomi V, et al. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer. Scand J Urol. 2019;53(5):295\u2013302. https:\/\/doi.org\/10.1080\/21681805.2019.1660707.","journal-title":"Scand J Urol"},{"key":"4561_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.euros.2020.10.007","volume":"22","author":"M Anttinen","year":"2020","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Viitala A, et al. Salvage magnetic resonance imaging-guided transurethral ultrasound ablation for localized radiorecurrent prostate cancer: 12-month functional and oncological results. Eur Urol Open Sci. 2020;22:79\u201387. https:\/\/doi.org\/10.1016\/j.euros.2020.10.007.","journal-title":"Eur Urol Open Sci"},{"issue":"5","key":"4561_CR42","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/bju.15268","volume":"127","author":"SM Nair","year":"2021","unstructured":"Nair SM, Hatiboglu G, Relle J, et al. Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective phase I study. BJU Int. 2021;127(5):544\u201352. https:\/\/doi.org\/10.1111\/bju.15268.","journal-title":"BJU Int"},{"issue":"3","key":"4561_CR43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/JU.0000000000001362","volume":"205","author":"L Klotz","year":"2021","unstructured":"Klotz L, Pavlovich CP, Chin J, et al. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer. J Urol. 2021;205(3):769\u201379. https:\/\/doi.org\/10.1097\/JU.0000000000001362.","journal-title":"J Urol"},{"issue":"4","key":"4561_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/end.2020.0511","volume":"35","author":"D Elterman","year":"2021","unstructured":"Elterman D, Li W, Hatiboglu G, et al. Relief of lower urinary tract symptoms after MRI-guided transurethral ultrasound ablation for localized prostate cancer: subgroup analyses in patients with concurrent cancer and benign prostatic hyperplasia. J Endourol. 2021;35(4):497\u2013505. https:\/\/doi.org\/10.1089\/end.2020.0511.","journal-title":"J Endourol"},{"issue":"12","key":"4561_CR45","doi-asserted-by":"publisher","first-page":"830.e9","DOI":"10.1016\/j.urolonc.2021.04.022","volume":"39","author":"A Lumiani","year":"2021","unstructured":"Lumiani A, Samun D, Sroka R, Muschter R. Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA). Urol Oncol. 2021;39(12):830.e9-830.e16. https:\/\/doi.org\/10.1016\/j.urolonc.2021.04.022.","journal-title":"Urol Oncol"},{"issue":"12","key":"4561_CR46","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1177\/0284185120976931","volume":"62","author":"P M\u00e4kel\u00e4","year":"2021","unstructured":"M\u00e4kel\u00e4 P, Anttinen M, Suomi V, et al. Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer. Acta Radiol. 2021;62(12):1687\u201395. https:\/\/doi.org\/10.1177\/0284185120976931.","journal-title":"Acta Radiol"},{"issue":"6","key":"4561_CR47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/bco2.175","volume":"3","author":"M Miura","year":"2022","unstructured":"Miura M, Takahashi S, Fukumoto M, Higashiyama H. Initial experience of transurethral ultrasound ablation of the prostate in Asia. BJUI Compass. 2022;3(6):405\u20137. https:\/\/doi.org\/10.1002\/bco2.175.","journal-title":"BJUI Compass"},{"issue":"1","key":"4561_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-023-01306-6","volume":"23","author":"I Peters","year":"2023","unstructured":"Peters I, Hensen B, Glandorf J, et al. First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study. BMC Urol. 2023;23(1):142. https:\/\/doi.org\/10.1186\/s12894-023-01306-6.","journal-title":"BMC Urol"},{"key":"4561_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.euros.2024.11.001","volume":"71","author":"M Anttinen","year":"2025","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Nurminen P, et al. Salvage magnetic resonance imaging-guided transurethral ultrasound ablation for localized radiorecurrent prostate cancer. Eur Urol Open Sci. 2025;71:69\u201377. https:\/\/doi.org\/10.1016\/j.euros.2024.11.001.","journal-title":"Eur Urol Open Sci"},{"issue":"9","key":"4561_CR50","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jvir.2025.05.024","volume":"36","author":"T Tricard","year":"2025","unstructured":"Tricard T, Cazzato RL, Schroeder A, et al. Magnetic resonance imaging-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: a prospective trial. J Vasc Interv Radiol. 2025;36(9):1401\u20138. https:\/\/doi.org\/10.1016\/j.jvir.2025.05.024.","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"4561_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032795","volume":"9","author":"MH Blanker","year":"2019","unstructured":"Blanker MH, Alma HJ, Devji TS, Roelofs M, Steffens MG, van der Worp H. Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care. BMJ Open. 2019;9(12):e032795. https:\/\/doi.org\/10.1136\/bmjopen-2019-032795.","journal-title":"BMJ Open"},{"key":"4561_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1069518","volume":"12","author":"M Alabousi","year":"2022","unstructured":"Alabousi M, Ghai S. Magnetic resonance imaging-guided ultrasound ablation for prostate cancer - a contemporary review of performance. Front Oncol. 2022;12:1069518. https:\/\/doi.org\/10.3389\/fonc.2022.1069518.","journal-title":"Front Oncol"},{"issue":"4","key":"4561_CR53","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.juro.2010.11.079","volume":"185","author":"HU Ahmed","year":"2011","unstructured":"Ahmed HU, Freeman A, Kirkham A, et al. Focal therapy for localized prostate cancer: a phase I\/II trial. J Urol. 2011;185(4):1246\u201354. https:\/\/doi.org\/10.1016\/j.juro.2010.11.079.","journal-title":"J Urol"},{"issue":"1","key":"4561_CR54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","volume":"71","author":"M Valerio","year":"2017","unstructured":"Valerio M, Cerantola Y, Eggener SE, et al. New and established technology in focal ablation of the prostate: a systematic review. Eur Urol. 2017;71(1):17\u201334. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.044.","journal-title":"Eur Urol"},{"issue":"1","key":"4561_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-04840-6","volume":"42","author":"SJ Peretsman","year":"2024","unstructured":"Peretsman SJ, Emberton M, Fleshner N, Shoji S, Bahler CD, Miller LE. High-intensity focused ultrasound with visually directed power adjustment for focal treatment of localized prostate cancer: systematic review and meta-analysis. World J Urol. 2024;42(1):175. https:\/\/doi.org\/10.1007\/s00345-024-04840-6.","journal-title":"World J Urol"},{"issue":"6","key":"4561_CR56","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26400","volume":"14","author":"YF Chin","year":"2022","unstructured":"Chin YF, Lynn N. Systematic review of focal and salvage cryotherapy for prostate cancer. Cureus. 2022;14(6):e26400. https:\/\/doi.org\/10.7759\/cureus.26400.","journal-title":"Cureus"},{"issue":"7","key":"4561_CR57","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S1470-2045(22)00251-0","volume":"23","author":"B Ehdaie","year":"2022","unstructured":"Ehdaie B, Tempany CM, Holland F, et al. MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study. Lancet Oncol. 2022;23(7):910\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(22)00251-0.","journal-title":"Lancet Oncol"},{"issue":"5","key":"4561_CR58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/PPO.0b013e3181570121","volume":"13","author":"DF Penson","year":"2007","unstructured":"Penson DF. Quality of life after therapy for localized prostate cancer. Cancer J. 2007;13(5):318\u201326. https:\/\/doi.org\/10.1097\/PPO.0b013e3181570121.","journal-title":"Cancer J"},{"key":"4561_CR59","unstructured":"Profound Medical Inc. Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: A Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN). clinicaltrials.gov; 2025. Accessed June 23, 2026. https:\/\/clinicaltrials.gov\/study\/NCT05027477"},{"key":"4561_CR60","unstructured":"Profound Medical Inc. Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: A Prospective, Single-Arm, Pivotal Clinical Study. clinicaltrials.gov; 2025. Accessed June 23, 2026. https:\/\/clinicaltrials.gov\/study\/NCT02766543"},{"key":"4561_CR61","doi-asserted-by":"publisher","unstructured":"D., Filippiadis P. L., Pereira K. A., Hausegger A. G., Ryan C. A., Binkert (2026) CIRSE Standards of Practice for the Classification of Complications: The Modified CIRSE Classification System Abstract CardioVascular and Interventional Radiology 49(1) 2-6 .https:\/\/doi.org\/10.1007\/s00270-025-04200-w","DOI":"10.1007\/s00270-025-04200-w"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-026-04561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-026-04561-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-026-04561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:51:17Z","timestamp":1788979877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-026-04561-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":61,"alternative-id":["4561"],"URL":"https:\/\/doi.org\/10.1007\/s00270-026-04561-w","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study formal consent is not required.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study consent for publication is not required.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study informed consent is not required.","order":4,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"International Prospective Register of Systematic Reviews (PROSPERO) registration: CRD420261307850.","order":5,"name":"Ethics","label":"PROSPERO Registration Number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}